These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 2698902)

  • 21. Clinical benefits of Daflon 500 mg in the most severe stages of chronic venous insufficiency.
    Ramelet AA
    Angiology; 2001 Aug; 52 Suppl 1():S49-56. PubMed ID: 11510597
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical efficacy of micronized purified flavonoid fraction: an overview.
    Struckmann JR
    J Vasc Res; 1999; 36 Suppl 1():37-41. PubMed ID: 10474049
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Double-blind, placebo-controlled evaluation of clinical activity and safety of Daflon 500 mg in the treatment of acute hemorrhoids.
    Cospite M
    Angiology; 1994 Jun; 45(6 Pt 2):566-73. PubMed ID: 8203789
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A long term treatment with a venotropic drug. Results on efficacy and safety of Daflon 500 mg in chronic venous insufficiency.
    Guillot B; Guilhou JJ; de Champvallins M; Mallet C; Moccatti D; Pointel JP
    Int Angiol; 1989; 8(4 Suppl):67-71. PubMed ID: 2632651
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effects of horse-chestnut seed extract on transcapillary filtration in chronic venous insufficiency].
    Bisler H; Pfeifer R; Klüken N; Pauschinger P
    Dtsch Med Wochenschr; 1986 Aug; 111(35):1321-9. PubMed ID: 3527643
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of edema and increased capillary filtration in venous hypertension with total triterpenic fraction of Centella asiatica: a clinical, prospective, placebo-controlled, randomized, dose-ranging trial.
    De Sanctis MT; Belcaro G; Incandela L; Cesarone MR; Griffin M; Ippolito E; Cacchio M
    Angiology; 2001 Oct; 52 Suppl 2():S55-9. PubMed ID: 11666125
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Therapeutic effectiveness of flavonoids illustrated by daflon 500 mg].
    Hitzenberger G
    Wien Med Wochenschr; 1997; 147(18):409-12. PubMed ID: 9454438
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic efficacy of flavonoids in oedema following reperfusion on acutely ischaemic legs.
    Filis KA; Georgopoulos SE; Papas SC; Votteas V; Bastounis EA
    Int Angiol; 1999 Dec; 18(4):327-30. PubMed ID: 10811522
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and safety of a Butcher's broom preparation (Ruscus aculeatus L. extract) compared to placebo in patients suffering from chronic venous insufficiency.
    Vanscheidt W; Jost V; Wolna P; Lücker PW; Müller A; Theurer C; Patz B; Grützner KI
    Arzneimittelforschung; 2002; 52(4):243-50. PubMed ID: 12040966
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Study of capillary filtration by double labelling I131-albumin and Tc99m red cells. Application to the pharmacodynamic activity of Daflon 500 mg.
    Behar A; Lagrue G; Cohen-Boulakia F; Baillet J
    Int Angiol; 1988; 7(2 Suppl):35-8. PubMed ID: 3053941
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthetic Diosmin in the therapy of venous diseases.
    Signorelli S; Ferrara M; Tornetta D; Interlandi S; Amico-Roxas MT; Monaco S; Andreozzi GM
    Panminerva Med; 1987; 29(2):165-7. PubMed ID: 3627817
    [No Abstract]   [Full Text] [Related]  

  • 32. Vital capillaroscopy on microcirculation: pharmacodynamic activity of Daflon 500 mg in venous insufficiency.
    Balas P; Pagratis N
    Int Angiol; 1989; 8(4 Suppl):51-2. PubMed ID: 2632650
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of micronized purified flavonoid fraction (Daflon®) on improving individual symptoms, signs and quality of life in patients with chronic venous disease: a systematic review and meta-analysis of randomized double-blind placebo-controlled trials.
    Kakkos SK; Nicolaides AN
    Int Angiol; 2018 Apr; 37(2):143-154. PubMed ID: 29385792
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The chronobiology and clinical efficacy of Daflon in the treatment of chronic venous insufficiency].
    Menyhelyi G; Acsády G; Hetényi A; Dubeaux D; Radó G
    Ter Arkh; 1997; 69(4):46-8. PubMed ID: 9213959
    [No Abstract]   [Full Text] [Related]  

  • 35. Evaluation of haemorheological and microcirculatory disturbances in chronic venous insufficiency: activity of Daflon 500 mg.
    Le Dévéhat C; Khodabandehlou T; Vimeux M; Kempf C
    Int J Microcirc Clin Exp; 1997; 17 Suppl 1():27-33. PubMed ID: 9477042
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The drug therapy of chronic venous insufficiency (a trial of the clinical use of the preparation Detralex)].
    Iablokov EG; Bogachev VIu; Domoradskaia AI
    Ter Arkh; 1996; 68(10):80-1. PubMed ID: 9026954
    [TBL] [Abstract][Full Text] [Related]  

  • 37. At the crossroads of venous insufficiency and hemorrhoidal disease: Daflon 500 mg--repercussions of venous insufficiency on everyday life.
    Launois R
    Angiology; 1994 Jun; 45(6 Pt 2):495-504. PubMed ID: 8203779
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Laser Doppler and transcutaneous oximetry: modern investigations to assess drug efficacy in chronic venous insufficiency.
    Belcaro G; Cesarone MR; de Sanctis MT; Incandela L; Laurora G; Février B; Wargon C; De Gregoris P
    Int J Microcirc Clin Exp; 1995; 15 Suppl 1():45-9. PubMed ID: 8748889
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative efficacy of a single daily dose of two capsules Cyclo 3 Fort in the morning versus a repeated dose of one capsule morning and noon. A one-month study.
    Boccalon H; Causse C; Yubero L
    Int Angiol; 1998 Sep; 17(3):155-60. PubMed ID: 9821028
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A double-blind, placebo-controlled trial of a new veno-active flavonoid fraction (S 5682) in the treatment of symptomatic capillary fragility.
    Galley P; Thiollet M
    Int Angiol; 1993 Mar; 12(1):69-72. PubMed ID: 8376915
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.